Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Cost of Revenue (2022 - 2025)

Historic Cost of Revenue for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $4.3 million.

  • Lucid Diagnostics' Cost of Revenue rose 579.39% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.4 million, marking a year-over-year decrease of 294.64%. This contributed to the annual value of $16.5 million for FY2024, which is 35.97% up from last year.
  • Latest data reveals that Lucid Diagnostics reported Cost of Revenue of $4.3 million as of Q3 2025, which was up 579.39% from $4.0 million recorded in Q2 2025.
  • In the past 5 years, Lucid Diagnostics' Cost of Revenue registered a high of $5.0 million during Q4 2022, and its lowest value of $3.3 million during Q1 2022.
  • Moreover, its 4-year median value for Cost of Revenue was $4.1 million (2024), whereas its average is $4.1 million.
  • Examining YoY changes over the last 5 years, Lucid Diagnostics' Cost of Revenue showed a top increase of 2438.22% in 2023 and a maximum decrease of 1206.86% in 2023.
  • Over the past 4 years, Lucid Diagnostics' Cost of Revenue (Quarter) stood at $5.0 million in 2022, then dropped by 12.07% to $4.4 million in 2023, then decreased by 9.17% to $4.0 million in 2024, then increased by 7.17% to $4.3 million in 2025.
  • Its Cost of Revenue was $4.3 million in Q3 2025, compared to $4.0 million in Q2 2025 and $4.1 million in Q1 2025.